Shortwave Life Sciences (AQSE:PSY) Interest Expense : £ Mil (TTM As of . 20)

View and export this data going back to 2022. Start your Free Trial

What is Shortwave Life Sciences Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Shortwave Life Sciences's interest expense for the six months ended in . 20 was £ 0.00 Mil. Shortwave Life Sciences does not have enough years/quarters to calculate its interest expense for the trailing twelve months (TTM) ended in . 20.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Shortwave Life Sciences's Operating Income for the six months ended in . 20 was £ 0.00 Mil. Shortwave Life Sciences's Interest Expense for the six months ended in . 20 was £ 0.00 Mil. Shortwave Life Sciences did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Shortwave Life Sciences Interest Expense Historical Data

The historical data trend for Shortwave Life Sciences's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shortwave Life Sciences Interest Expense Chart

Shortwave Life Sciences Annual Data

Trend

Interest Expense

Shortwave Life Sciences Semi-Annual Data

Interest Expense

Shortwave Life Sciences Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Shortwave Life Sciences (AQSE:PSY) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Shortwave Life Sciences's Interest Expense for the six months ended in . 20 was £0.00 Mil. Its Operating Income for the six months ended in . 20 was £0.00 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in . 20 was £0.00 Mil.

Shortwave Life Sciences's Interest Coverage for the quarter that ended in . 20 is calculated as

Shortwave Life Sciences had no long-term debt ⁽¹⁾.

The higher the ratio, the stronger the company's financial strength is.

Shortwave Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shortwave Life Sciences PLC (AQSE:PSY) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

17 Hanover Square, London, GBR, W1S 1BN

Website

https://www.shortwavelifesciences.com

Shortwave Life Sciences PLC is a biopharmaceutical company focused in advancing pioneering therapies in mental health care, also it is involved in developing novel drug combinations and delivery methods to treat patients suffering from mental health disorders. It identifies, operates and creates value from early-stage, breakthrough initiatives, with an initial focus on eating disorders.